<i id='AA34720885'><strike id='AA34720885'><tt id='AA34720885'><pre id='AA34720885'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Walensky prepares to leave CDC — and Congress — behind 
TikTok, Instagram influencers need more rules for drug ads 
Moonlake's readout produced a cash windfall. Risks remain 
FDA has safety concerns on CRISPR 
Psychedelics group wrestles with new pharma identity 
Readout Newsletter: The latest from Bristol, Sarepta, and Novartis
Psychedelics group wrestles with new pharma identity 
HPV vaccine, cervical cancer study delivers historic results 
What does generative AI mean for health care? We asked experts 
STAT Wunderkinds: Ruey Hu's digital tools for parsing research 
BioMarin wins approval for gene therapy to treat hemophilia A
TikTok, Instagram influencers need more rules for drug ads 
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
Traditional Chinese medicine benefits explored in new JAMA study 
As demand for Covid shots wanes, Moderna seeks its next success 